Should You Buy HealthEquity, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, HealthEquity, Inc. (HQY) stands out as one of the highest-quality businesses in our coverage universe, earning a Quality of Company score of 9.5/10. At a current price of $96.51 and a market capitalization of $8.0B, the core investment question is whether the stock offers a compelling entry point relative to its estimated intrinsic value.
The short answer: 7 of 11 CirclFi valuation models project upside for HealthEquity, Inc. (HQY) at $96.51 — the model consensus leans bullish, with a Quality Score of 9.5/10 and Value-Trap risk of 12/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for HealthEquity, Inc. (HQY) in 2026?
What Is the Bull Case vs the Bear Case for HealthEquity, Inc. (HQY)?
| Bull case — $242.00 target (+150.8%) | Bear case — $8.43 target (-91.3%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, HealthEquity, Inc.'s quality score of 9.5/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. | According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model sees the stock as overvalued with a fair value of $8.43 (-91.3%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $242.00 (+150.8%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +242.0% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
How Does HQY Compare to Its Health Information Services Peers?
Valuation data pages: DOCS · VEEV · ZCMD · HSTM · MNDR · SPOK · LFMD · CRVW · LGMK
Which Other Stocks Score Like HQY on Quality?
Closest companies to HQY’s Quality of Company score of 9.5/10, across all industries.
- CARG — CarGurus, Inc. (QOC 9.5) · analysis
- UVE — Universal Insurance Holdings, Inc. (QOC 9.5) · analysis
- PLMR — Palomar Holdings, Inc. (QOC 9.5) · analysis
- NXPI — NXP Semiconductors N.V. (QOC 9.5) · analysis
- CRM — Salesforce, Inc. (QOC 9.5) · analysis
- APP — AppLovin Corporation (QOC 9.5) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Health Information Services Screens Does HQY Appear In?
So Is HealthEquity, Inc. (HQY) Worth Buying in 2026?
HealthEquity, Inc. leans positive in our analysis — 7/11 models bullish, median fair value of $105.11 vs. $96.51, QOC 9.5/10. The case is constructive but not overwhelming, and the 3 dissenting models shouldn't be dismissed. Position sizing should reflect this moderate conviction level.
These are quantitative model outputs, not investment recommendations. HealthEquity, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About HQY Stock?
Should I buy HQY stock right now?
Based on CirclFi's multi-model analysis, 7 of 11 models see upside for HQY at $96.51. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 9.5/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in HealthEquity, Inc.?
Key risks include: wide model disagreement (2771% spread), signaling high uncertainty; general market and sector-specific risks affecting Health Information Services companies. Always diversify and consult a financial advisor.
How does HQY compare to its competitors?
Among Health Information Services peers, HQY holds a Quality Score of 9.5/10. Comparable companies include DOCS (QOC 9.5), VEEV (QOC 9.3), ZCMD (QOC 1.6). The relative ranking helps investors identify whether HQY offers better fundamental quality than alternatives in the same sector.
Is HQY a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. HQY's Quality Score of 9.5/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy HQY at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $8.43 to $242.00. At $96.51, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for HQY.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad